billHR5068Event Tuesday, January 13, 2026Analyzed

MORE Act

Bullish

Summary

The MORE Act (HR5068) is an early-stage bill to federally decriminalize cannabis. It has been referred to nine committees and has 72 cosponsors, but remains in the House with no Senate companion. The bill authorizes no direct funding and faces a long legislative path. Market impact is currently minimal.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.The MORE Act is in early legislative stage with no near-term market impact.
  • 2.No direct funding is authorized; the bill's mechanism is regulatory decriminalization.
  • 3.If passed, cannabis operators like $TLRY, $CGC, and $MSOS would benefit structurally.

Market Implications

The bill is too early-stage to drive market moves. Cannabis stocks may see speculative interest if the bill gains momentum, but currently there is no actionable catalyst. Investors should monitor committee hearings and Senate companion bill introduction.

Full Analysis

  1. What happened and its current status: The Marijuana Opportunity Reinvestment and Expungement Act (MORE Act) was introduced in the House on August 29, 2025, by Rep. Nadler (D-NY) and referred to nine committees. As of January 13, 2026, it was referred to the Subcommittee on Conservation, Research, and Biotechnology. The bill is in early stage with no further action. 2) The money trail: The bill does not authorize or appropriate any direct funding. It establishes a trust fund for community reinvestment funded by an excise tax on cannabis, but no dollar amount is specified. Authorization is not appropriation; actual spending would require separate appropriations bills. 3) Structural winners and losers: If passed, the bill would benefit U.S. cannabis operators like $TLRY, , and the ETF by removing federal prohibition, enabling interstate commerce, banking access, and exchange uplisting. No tickers are negatively impacted directly. 4) Market data: No real market data provided for cannabis stocks. 5) Timeline: The bill must pass the House, Senate, and be signed by the President. With 72 cosponsors and a Democratic sponsor, but a Republican-controlled House (119th Congress), passage is highly uncertain. No Senate companion bill exists.

Intelligence Surface

Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures

Unconfirmed

No confirming evidence found yet from contracts, insider trades, or congressional activity

$$TLRY▲ Bullish
Est. $50.0M$200.0M revenue impact

What the bill does

Decriminalization and descheduling of cannabis under the Controlled Substances Act, eliminating federal criminal penalties for manufacture, distribution, and possession.

Who must act

Federal law enforcement agencies (DEA, DOJ) and cannabis businesses operating in states with legal markets.

What happens

Removes federal prohibition risk for state-legal cannabis operators, enabling interstate commerce, banking access, and potential uplisting to major U.S. stock exchanges.

Stock impact

TLRY, as a leading multi-state operator with U.S. and Canadian exposure, would benefit from reduced regulatory burden, improved capital access, and potential revenue growth from expanded legal market participation.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

proclamationJul 20, 2026

Imposing Additional Duties to Offset Canadian Discrimination Against the Commerce of the United States with Respect to Motor Vehicles

This proclamation imposes a 50% ad valorem duty on certain Canadian products, effective August 19, 2026, under Section 338 of the Tariff Act of 1930, to offset Canada's discriminatory 25% tariff and tariff-rate quota on U.S. motor vehicle exports, which have reduced U.S. auto exports to Canada by 22% and shifted demand to competitors like Mexico, Japan, Korea, and Germany.

proclamationJul 20, 2026

Imposing Additional Duties to Offset Canadian Discrimination Against the Commerce of the United States with Respect to Dairy

President Trump, citing Section 338 of the Tariff Act of 1930, imposes a 50% additional ad valorem duty on certain Canadian products (listed in Annex II) effective August 19, 2026, to offset Canada's discriminatory dairy tariff-rate quota allocation that disadvantages U.S. cheese exporters compared to EU exporters under CETA. The action aims to pressure Canada to remove the discrimination and expand opportunities for U.S. dairy producers within the U.S. market.

proclamationJul 20, 2026

Imposing Additional Duties to Offset Canadian Discrimination Against the Commerce of the United States with Respect to Alcoholic Beverages

This proclamation imposes a 50% ad valorem duty on certain Canadian products under Section 338 of the Tariff Act of 1930, effective August 19, 2026, to retaliate against Canadian provincial bans on U.S. alcoholic beverages that have reduced U.S. exports by 81%. It directs the U.S. Trade Representative and Customs and Border Protection to implement the duties via the Harmonized Tariff Schedule, targeting a range of Canadian goods to offset the trade disadvantage.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →